The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Eisai; Novartis; Roche
Consulting or Advisory Role - Novartis
A phase 2 study of s-1 plus leucovorin in patients with untreated advanced cholangiocarcinoma (CCA).
 
Suebpong Tanasanvimon
Honoraria - Boehringer Ingelheim; Celgene; Eisai; Novartis; Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Eisai; Novartis; Roche
Travel, Accommodations, Expenses - Roche; Sanofi
 
Teerapat Ungtrakul
No Relationships to Disclose
 
Nattaya Poovorawan
No Relationships to Disclose
 
Napa Parinyanitikul
No Relationships to Disclose
 
Chanida Vinayanuwattikun
Honoraria - AstraZeneca
 
Siyamol Mingmalairak
No Relationships to Disclose
 
Sutima Luangdilok
No Relationships to Disclose
 
Wisut Lamlertthon
No Relationships to Disclose
 
Virote Sriuranpong
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Roche; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Roche; Sanofi